Sanway Spring

Sanway Spring is a prominent Chinese venture capital firm and biotechnology operator specializing in the life sciences, healthcare, and high-tech sectors. Founded in 2008 and headquartered in Changsha, the firm manages a multi-billion RMB investment portfolio and is a key driver in the Chinese molecular diagnostics ecosystem. Sanway Spring is most notable for its strategic partnership with Sansure Biotech and Asep Medical Holdings to establish Hunan Sanway SepSMART, a joint venture dedicated to commercializing advanced AI-driven sepsis diagnostic technologies in Greater China. The firm actively incubates and invests in high-growth companies across the biotech value chain, focusing on innovative therapeutics and precision diagnostics. Its portfolio includes industry leaders such as Sansure Biotech and Wondfo Biotech, positioning Sanway Spring as a major player in China's health tech landscape.